Profiles: Page

The latest opinion pieces by industry thought leaders

  • Amit Etkin horizontal
    Image attribution tooltip
    Permission granted by Amit Etkin
    Image attribution tooltip

    Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds

    After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.

    Alexandra Pecci • Oct. 11, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    PharmaVoice staff • Sept. 15, 2022
  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Image attribution tooltip

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

    PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    PharmaVoice staff • Sept. 15, 2022
  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

    PharmaVoice staff • Sept. 15, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    PharmaVoice staff • Sept. 15, 2022
  • A portrait of Fahti Khosrowshahi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Fahti Khosrowshahi
    Image attribution tooltip

    Disrupters: Fahti Khosrowshahi

    The president, CEO and founder of Ceek Women’s Health is on a mission to upend the OBGYN market.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jennifer Kelly framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Kelly
    Image attribution tooltip

    Tech Wizards: Jennifer Kelly

    The president of patient experience is helping transform clinical trials with an innovative platform.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Abigail Jenkins framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Abigail Jenkins
    Image attribution tooltip

    Disrupters: Abigail Jenkins

    With the belief that empathy is critical to leadership, the former chief commercial and business officer of Lyndra Therapeutics has a strong track record of building teams and accelerating progress.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Adrelia Allen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Adrelia Allen
    Image attribution tooltip

    DE&I Champions: Adrelia Allen

    Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Amanda Ryan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Amanda Ryan
    Image attribution tooltip

    DE&I Champions: Amanda Ryan

    G3 Life Sciences’ president is lighting a fire to increase access to healthcare and diversity in trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Amy C. Peterson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Amy C. Peterson
    Image attribution tooltip

    Innovators: Dr. Amy Peterson

    The president and chief operating officer of CytomX is fighting to change the course of cancer as a leader in cutting-edge treatments.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Andrew Miller framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Andrew Miller
    Image attribution tooltip

    Entrepreneurs: Andrew Miller

    The founder and COO of Karuna Therapeutics is leveraging a combination of persistence and adaptability to scale up the biopharmaceutical company.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ann Barnes framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ann Barnes
    Image attribution tooltip

    DE&I Champions: Ann Barnes

    The CEO of Intelligent Medical Objects is growing her company’s diversity initiatives — and its bottom line.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Baba Shetty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Baba Shetty
    Image attribution tooltip

    Tech Wizards: Baba Shetty

    The pragmatic president of technology and data solutions at Syneos Health helps healthcare companies do what they imagine.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Barbara Klencke framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Barbara Klencke
    Image attribution tooltip

    Innovators: Dr. Barbara Klencke

    The chief medical officer at Sierra Oncology, a GSK company, is working to make high-impact changes for rare cancer patients.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Barbara Wirostko framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Barbara Wirostko
    Image attribution tooltip

    Entrepreneurs: Dr. Barbara Wirostko

    Qlaris Bio’s CMO and co-founder has her sights on bringing life-changing treatments to patients with debilitating eye diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Image attribution tooltip

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Beth Crouse framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Beth Crouse
    Image attribution tooltip

    Entrepreneurs: Beth Crouse

    The 2nd Spark CEO is on a mission to create ‘brand fans’ and bring meaningful marketing experiences to healthcare.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Bobak Azamian framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Bobak Azamian
    Image attribution tooltip

    Entrepreneurs: Dr. Bobak Azamian

    The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Carl Turner framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carl Turner
    Image attribution tooltip

    Disrupters: Carl Turner

    How Klick’s first-ever chief brand strategy officer is relying on collaboration to advance innovative strategies for clients and opportunities for people of color.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Carol Lynch framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carol Lynch
    Image attribution tooltip

    Legacy Leaders: Carol Lynch

    The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Chris Round framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Chris Round
    Image attribution tooltip

    Legacy Leaders: Chris Round

    The president of EMD Serono, the U.S. and Canadian healthcare business unit of Merck KGaA, Darmstadt, Germany, has the company firing on all cylinders for near- and long-term growth.

    PharmaVoice staff • Sept. 6, 2022